For Medicare Advantage enrollees, the ICD-10 codes for the CCW-developed algorithms for AMI, stroke, obesity, and diabetes (not including Type 1), plus ICD-10 codes specified above for overweight and peripheral arterial disease, were used to identify whether enrollees were eligible for the new use of Wegovy, based on 2020 encounter data and utilizing a within-year lookback period for all conditions (rather than ever, or in some cases a 2-year lookback that is used for traditional Medicare enrollees)
For a fuller treatment of when the intravenous route is worth the cost and when it is not, see our comparison of IV versus oral supplements
Exenatide can help regulate appetite and support weight reduction over time
LSUNGSMITTEL 2
[archived link] Can New Drugs Help Millions of Americans with Obesity
If purchased through the Lilly Savings Card program, the price of Zepbound is as low as $25 per month when private insurance covers it, or if insurance does not cover Zepbound, the price can be reduced by $497 per month